Pharmaceutical composition and application thereof in prevention and treatment of rice panicle blight
Through the pharmaceutical composition of cyperin and geranium lignin, especially under a specific mass ratio, the prevention and treatment effect of rice ear blight is significantly improved, the problem of prevention and treatment of rice ear blight is solved, and the green and safe agricultural application solutions are provided. .
Patent Information
- Application Number
- CN202410927212.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-15
AI Technical Summary
Rice ear blight leads to a decrease in fruiting rate, decay of grains and health threats for humans and animals, and lacks effective prevention and control drugs. No resistant rice varieties have been found in the prior art, making it difficult to prevent and control.
The pharmaceutical composition using marmotile and geranium lignin, with a mass ratio of 3-9:1, is used to prepare agents for preventing and treating rice ear blight, especially in the range of 4-8:1, 7: The best effect is 1.
It significantly improves the prevention and treatment effect of rice ear blight, and the pharmaceutical composition is green and safe, and is suitable for agricultural promotion and application.
Smart Images

Figure BDA0004938568710000011 
Figure BDA0004938568710000021 
Figure BDA0004938568710000041
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of agriculture, and in particular to a pharmaceutical composition and use thereof in preventing and treating rice panicle blight. Background Art
[0002] Rice panicle blight is one of the important rice diseases, which seriously threatens the high and stable yield of rice. With global warming and the widespread application of mechanized transplanting technology, rice panicle blight is becoming more and more common.
[0003] When rice is infected with panicle blight, it can cause a decrease in the rice fruiting rate and grain discoloration, decay, and deformity. The toxins produced by the pathogen can also harm the health of humans and animals. At the same time, because the early stage of rice panicle blight is easily ignored (rice has no obvious symptoms in the early stage of infection and is basically the same as healthy rice) and there is a lack of effective prevention and control drugs, the harm caused by it is extremely serious.
[0004] At present, the integrated prevention and control of rice panicle blight still needs further research, and no rice variety showing complete resistance has been found so far. Summary of the invention
[0005] The purpose of the present invention is to provide a pharmaceutical composition and its use in preventing and treating rice ear blight, so as to solve the problems existing in the above-mentioned prior art and achieve efficient prevention and treatment of rice ear blight.
[0006] To achieve the above object, the present invention provides the following solutions:
[0007] One of the technical solutions of the present invention is to provide a pharmaceutical composition for preventing and treating rice panicle blight, comprising formononetin and diosmethin; the mass ratio of the formononetin to diosmethin is 3-9:1.
[0008] As a further preferred embodiment of the present invention, the mass ratio of formononetin to diosmetin is 4-8:1.
[0009] As a further preferred embodiment of the present invention, the mass ratio of formononetin to diosmetin is 7:1.
[0010] In the present invention, the structural formula of formononetin (CAS No.: 485-72-3) is as follows:
[0011]
[0012] The structural formula of geraniol (CAS: 520-34-3) is as follows:
[0013]
[0014] The second technical solution of the present invention is to provide the use of the above-mentioned pharmaceutical composition in the preparation of a drug for preventing and treating rice panicle blight.
[0015] The third technical solution of the present invention is to provide a medicament for preventing and treating rice panicle blight, wherein the active ingredient includes the above-mentioned pharmaceutical composition.
[0016] As a further preferred embodiment of the present invention, in the agent, the total concentration of formononetin and dioscorea lignin is 12 mg / L-14 mg / L.
[0017] As a further preferred embodiment of the present invention, the medicament further comprises pharmaceutically acceptable excipients.
[0018] As a further preferred embodiment of the present invention, the auxiliary materials include a dispersant, a stabilizer and / or a co-solvent.
[0019] A fourth technical solution of the present invention is to provide the use of the above-mentioned pharmaceutical composition or agent in preventing and treating rice panicle blight.
[0020] The present invention discloses the following technical effects:
[0021] The invention provides a pharmaceutical composition for preventing and treating rice panicle blight, comprising formononetin and diosmethin components. When formononetin and diosmethin are compounded in a mass ratio of 3-9:1, a good rice panicle blight prevention and treatment effect is exhibited, and a synergistic effect is exhibited within a compounding range of a mass ratio of 4-8:1, and a compounding effect of 7:1 is optimal.
[0022] The drug combination for preventing and treating rice panicle blight of the present invention adopts natural plant components, is green and safe, and is suitable for agricultural promotion and application. DETAILED DESCRIPTION
[0023] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0024] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0025] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0026] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0027] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0028] Example 1
[0029] 1. Experimental materials: Burkholderia glume (LMG2196).
[0030] 2. Experimental methods:
[0031] The inhibitory effects of each single compound and the combined composition on Burkholderia glume were determined by plate inhibition test:
[0032] Different concentrations of a single compound and a compounded combination were added to a PDA culture medium to obtain a plate containing the drug, and a plate without the drug was used as a blank control; a bacterial disc was then punched along the edge of the cultured colony using a puncher, and then the punched bacterial disc was inoculated onto the above-mentioned plate using a sterilized inoculation needle, and cultured at a constant temperature of 25°C for 7 days.
[0033] After constant temperature culture, the colony expansion diameter was measured and the growth inhibition rate of different compounds on bacteria was calculated. The calculation formula is as follows:
[0034] Inhibition rate (%) = (expanded diameter of drug-free plate - expanded diameter of drug-containing plate) / expanded diameter of drug-free plate × 100%.
[0035] 3. Statistical Analysis
[0036] Statistical analysis was performed using the SAS statistical analysis system to obtain the EC values of single compounds and combinations. 50The synergistic coefficient SR of the composition was calculated according to the Wadley method, and the combined effect of the compounded composition was evaluated (wherein SR < 0.5 represents an antagonistic effect, 0.5 ≤ SR ≤ 1.5 represents an additive effect, and SR > 1.5 represents a synergistic effect).
[0037] Composition EC 50 The calculation formula of the theoretical value (X1) is shown in Formula I:
[0038] X1=(P A +P B ) / (P A / A+P B / B) Formula I;
[0039] Where:
[0040] X1: Composition EC 50 Theoretical value (mg / L);
[0041] P A : The percentage content of compound A in the composition (%);
[0042] P B : The percentage content of compound B in the composition (%);
[0043] A: EC of compound A 50 Value (mg / L);
[0044] B: EC of compound B 50 Value (mg / L).
[0045] The calculation formula of the synergistic coefficient SR is shown in Formula II:
[0046] SR = X1 / X2 × 100% Formula II;
[0047] Where:
[0048] SR: synergistic factor of the composition;
[0049] X1: Composition EC 50 Theoretical value (mg / L);
[0050] X2: Composition EC 50 Measured value (mg / L).
[0051] 4. Experimental Results
[0052] The toxicity of single compounds formononetin and diosmin and their combination to Burkholderia glumes was determined, and the results are shown in Table 1.
[0053] Table 1
[0054]
[0055] It can be seen from Table 1 that when formononetin and diosmetin are compounded in the range of 4-8:1, the SR value is greater than 1.5, showing synergistic enhancement. Among them, when the mass ratio of the two is 7:1, the SR value reaches 2.53, reflecting the optimal synergistic inhibition effect.
[0056] Example 2
[0057] 1. Experimental location: a rice experimental field in Jiangxi Province.
[0058] 2. Preparation of the drug: Using 6 vol.% DMSO aqueous solution as solvent, different concentrations of formononetin and dioscorea lignin and their composite drug were prepared.
[0059] 3. Experimental method: The rice experimental field was divided into several equal-sized plots (10 m 2 ), and on the third day after the rice heading period, the concentration of 3*10 8 Spray a bacterial suspension of Burkholderia glume (LMG2196) at a concentration of cfu / mL onto the leaf surface until droplets fall off. Then tie the leaves with ropes to keep them moist. Remove the ropes after 3 days to allow bacteria to invade.
[0060] On the 6th day after spraying the bacterial suspension, different concentrations of formononetin and dioscorea lignin and their combined combination were sprayed in each plot. The spraying was done twice during the growth period with an interval of 7 days. The control group was sprayed with an equal amount of 6 vol.% DMSO aqueous solution.
[0061] 4. Experimental results: After the rice growth period, the incidence of rice panicle blight and the control effect were statistically analyzed:
[0062] Incidence rate (%) = (number of infected plants / total number of plants) × 100%;
[0063] Prevention effect (%) = (incidence rate of control group - incidence rate of treatment group) / incidence rate of control group × 100%.
[0064] 5. Result statistics: The experimental results are shown in Table 2.
[0065] Table 2
[0066]
[0067] It can be seen that the single compound active ingredients of formononetin and diosmethicone have a certain inhibitory effect on rice panicle blight, and the combination of formononetin and diosmethicone can significantly improve the control effect of rice panicle blight. Moreover, when the mass ratio of formononetin to diosmethicone is 7:1, the effect is optimal.
[0068] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. A pharmaceutical composition for preventing and treating rice panicle blight, characterized in that: The invention comprises formononetin and diosmetin; the mass ratio of the formononetin to diosmetin is 3-9:
1.
2. The pharmaceutical composition according to claim 1, characterized in that The mass ratio of formononetin to diosmetin is 4-8:
1.
3. The pharmaceutical composition according to claim 1, characterized in that The mass ratio of formononetin to diosmetin is 7:
1.
4. Use of the pharmaceutical composition according to any one of claims 1 to 3 in the preparation of an agent for preventing and treating rice panicle blight.
5. A medicament for preventing and treating rice panicle blight, characterized in that: The active ingredient comprises the pharmaceutical composition according to any one of claims 1 to 3.
6. The drug according to claim 5, characterized in that The total concentration of formononetin and diosmetin is 12 mg / L-14 mg / L.
7. The agent according to claim 5, characterized in that Also included are pharmaceutically acceptable excipients.
8. The medicament according to claim 5, characterized in that The auxiliary materials include dispersants, stabilizers and / or co-solvents.
9. Use of the pharmaceutical composition according to any one of claims 1 to 3 or the agent according to any one of claims 5 to 8 in preventing and treating rice panicle blight.
Citation Information
Patent Citations
Application of natural source flavonoid compounds as antibacterial agents in inhibition of plant pathogenic bacteria
CN113455507A
